Experts release appropriate use recommendations for Alzheimer’s disease blood biomarkers

By | August 1, 2022
Alzheimer’s disease blood biomarkers (BBMs) may revolutionize the diagnosis of Alzheimer’s in the future, but are not yet ready for widespread use, according to a newly-published article by leading international clinicians and researchers convened by the Alzheimer’s Association.